Sweden · Delayed Price · Currency is SEK Dextech Medical AB Statistics
Total Valuation
XSAT:DEX has a market cap or net worth of SEK 129.40 million. The enterprise value is 115.33 million.
| Market Cap | 129.40M |
| Enterprise Value | 115.33M |
Important Dates
The last earnings date was Monday, November 3, 2025.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XSAT:DEX has 18.49 million shares outstanding. The number of shares has decreased by -1.00% in one year.
| Current Share Class | 18.49M |
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | -1.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.20% |
| Owned by Institutions (%) | n/a |
| Float | 7.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.34 |
| PB Ratio | 5.23 |
| P/TBV Ratio | 8.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -23.24 |
| EV / Sales | 33.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 43.24
| Current Ratio | 43.24 |
| Quick Ratio | 43.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.64% and return on invested capital (ROIC) is -12.61%.
| Return on Equity (ROE) | -18.64% |
| Return on Assets (ROA) | -12.56% |
| Return on Invested Capital (ROIC) | -12.61% |
| Return on Capital Employed (ROCE) | -22.45% |
| Revenue Per Employee | 3.47M |
| Profits Per Employee | -4.96M |
| Employee Count | 1 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.56% in the last 52 weeks. The beta is 1.38, so XSAT:DEX's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +55.56% |
| 50-Day Moving Average | 8.23 |
| 200-Day Moving Average | 6.28 |
| Relative Strength Index (RSI) | 41.44 |
| Average Volume (20 Days) | 10,884 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XSAT:DEX had revenue of SEK 3.47 million and -4.96 million in losses. Loss per share was -0.27.
| Revenue | 3.47M |
| Gross Profit | 3.17M |
| Operating Income | -5.37M |
| Pretax Income | -4.96M |
| Net Income | -4.96M |
| EBITDA | -6.08M |
| EBIT | -5.37M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 14.08 million in cash and n/a in debt, giving a net cash position of 14.08 million or 0.76 per share.
| Cash & Cash Equivalents | 14.08M |
| Total Debt | n/a |
| Net Cash | 14.08M |
| Net Cash Per Share | 0.76 |
| Equity (Book Value) | 24.76M |
| Book Value Per Share | 1.34 |
| Working Capital | 14.24M |
Cash Flow
| Operating Cash Flow | -451,610 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 91.57%, with operating and profit margins of -154.93% and -143.19%.
| Gross Margin | 91.57% |
| Operating Margin | -154.93% |
| Pretax Margin | -143.19% |
| Profit Margin | -143.19% |
| EBITDA Margin | -175.56% |
| EBIT Margin | -154.93% |
| FCF Margin | n/a |
Dividends & Yields
XSAT:DEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.00% |
| Shareholder Yield | 1.00% |
| Earnings Yield | -3.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |